Reports
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
![]() |
Co-codamol 30/500 effervescent tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
![]() |
Co-codamol 30/500 tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
![]() |
Co-danthramer capsules |
For terminally ill patients |
|
![]() |
Co-danthramer suspension |
For terminally ill patients |
|
![]() |
Co-danthrusate capsules |
For terminally ill patients |
|
![]() |
Co-magaldrox suspension |
Second line - when a lower sodium content is required. High relative cost. |
|
![]() |
Coal tar BP 10% w/w in Yellow Soft Paraffin |
Unlicensed special |
|
![]() |
Coal tar BP 2% w/w in Yellow Soft Paraffin |
Unlicensed special |
|
![]() |
Coal tar BP 5% w/w in Yellow Soft Paraffin |
Unlicensed special |
|
![]() |
Coal tar solution BP 3.3% w/w and propylene glycol 20% w/w in Synalar® gel |
Unlicensed special |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- Next page
- Last page